Angiotensin II upregulates Kv1.5 expression through ROS-dependent transforming growth factor-beta1 and extracellular signal-regulated kinase 1/2 signalings in neonatal rat atrial myocytes |
| |
Authors: | Guihua Lu Shuang Xu Longyun Peng Zhibin Huang Yesong Wang Xiuren Gao |
| |
Affiliation: | 1. Department of Cardiology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China;2. Key Laboratory on Assisted Circulation, Ministry of Health, Guangzhou 510080, China |
| |
Abstract: | Kv1.5 potassium channel represents a promising target for atrial fibrillation (AF) therapy. During AF, the renin–angiotensin system is markedly activated. Recent evidence indicates that angiotensin II (Ang II) can upregulate Kv1.5 channel, but the mechanism remains unknown. In this study, we report that Ang II-mediated transforming growth factor-beta1 (TGF-β1)/Smad2/3 and extracellular signal-regulated kinase (ERK) 1/2 signalings are involved in atrial Kv1.5 expression. In neonatal rat atrial myocytes, quantitative PCR and Western blotting revealed that Ang II upregulated TGF-β1, synapse-associated protein 97 (SAP97) and Kv1.5 expression in a time- and concentration-dependent manner. The Ang II-induced upregulation of Kv1.5, SAP97 and phosphorylated Smad2/3 (P-Smad2/3) were reversed by the Ang II type 1 (AT1) receptor antagonist losartan, an anti-TGF-β1 antibody and the ERK 1/2 inhibitor PD98059 but not by the AT2 receptor antagonist PD123319. mRNA knockdown of either Smad2 or Smad3 blocked Ang II-induced expression of Kv1.5 and SAP97. These data suggest that AT1 receptor/TGF-β1/P-Smad2/3 and ERK 1/2 signalings are involved in Ang II-induced Kv1.5 and SAP97 expression. Flow cytometry and Western blotting revealed that losartan and the anti-TGF-β1 antibody diminished Ang II-induced reactive oxygen species (ROS) generation and that the antioxidants diphenyleneiodonium and N-acetyl cysteine inhibited Ang II-induced expression of P-Smad2/3, phosphorylated ERK (P-ERK) 1/2, Kv1.5, SAP97, suggesting that ROS participate in Kv1.5 and SAP97 regulation by modulating Ang II-induced P-Smad2/3 and P-ERK 1/2 expression. In conclusion, we demonstrate that ROS-dependent Ang II/AT1 receptor/TGF-β1/P-Smad2/3 and Ang II/ERK 1/2 signalings are involved in atrial Kv1.5 and SAP97 expression. Antioxidants would be beneficial for AF treatment through inhibiting atrial Kv1.5 expression. |
| |
Keywords: | AF, atrial fibrillation Ang II, angiotensin II AT1, angiotensin II type 1 AT2, angiotensin II type 2 SAP97, synapse-associated protein 97 TGF, transforming growth factor ERK, extracellular signal-regulated kinase P-ERK, phosphorylated ERK P-Smad, phosphorylated Smad DPI, diphenyleneiodonium NAC, N-acetyl cysteine RAS, renin&ndash angiotensin system ROS, reactive oxygen species siRNA, small interfering RNA HUVECs, human umbilical vein endothelial cells PASMCs, pulmonary artery smooth muscle cells |
本文献已被 ScienceDirect 等数据库收录! |
|